The focus of SIAPS’ support to DF will be improving the effectiveness, efficiency, transparency, and overall functioning of the regulatory system—including product registration, pharmacovigilance (PV), and inspection—to ensure the safety, efficacy, and quality of pharmaceutical products in circulation in the country. SIAPS will focus on improving pharmaceutical services at public hospitals, including the management of commodities, rational use of medicines, and patient safety.
SIAPS Final Report
